Shott sets out API process development plan for former Covance lab
Shott Trinova has confirmed its intention to offer API production and process development at the UK laboratory it acquired Covance.
Archives for February 25, 2016
DNA 'Trojan horse' dupes drug-resistant cancer cells
Researchers at Ohio State University are hiding cancer drugs inside a “molecular Trojan horse” in order to successfully infiltrate drug-resistant cells.
Novartis cooperating with South Korean authorities after raid
Novartis has confirmed its offices in South Korea were visited by local authorities earlier this week.
Cobra Biologics and UK CPI team on AAV vector production platform
Cobra Biologics and the UK Centre for Process Innovation (CPI) will develop a manufacturing system for the viruses used to deliver gene therapies.
Preclinical consolidation creating 'service desert,' says Swiss CRO Anapath
Anapath has seen a surge in histotechnology services from Europe pharma and rival CROs as consolidation in the preclinical sector has left a lack of capacity for such work.
Heat Biologics stops enrolment in trial arm testing HS-410 as a bladder cancer monotherapy
Heat Biologics will no longer enrol patients in the arm of a Phase II trial examining its cell therapy HS-410 (vesigenurtacel-L) as a monotherapy for bladder cancer.